Estée Lauder (EL): Turnaround Gains, But Valuation Limits Upside


Estée Lauder(EL) is no longer a simple prestige beauty compounder story. It is a turnaround story with real brand assets, real margin repair, and real execution risk. The bull case rests on facts that are now visible in the numbers: fiscal Q3 2026 net sales rose 5% to $3.712B, organic sales rose 2%, adjusted operating margin expanded 360 bps to 15.0%, adjusted EPS rose 40% to $0.91, and free cash flow for the first nine months climbed to $891M from $276M a year earlier. Management also raised FY2026 guidance and said it expects organic sales growth at the high end of the prior 1%-3% range, with adjusted operating margin of 10.7%-11.0%.
The bear case is just as concrete. Annual revenue fell from $17.74B in FY2022 to $14.29B in FY2025. FY2025 net income was a loss of $1.13B. Debt stood at $7.72B at June 30, 2025 against $2.92B of cash, and annual debt-to-equity reached 2.00. Travel retail disruption in Asia remains a live issue, the Americas are still rebuilding after years of share loss, and management flagged about $100M of tariff-related profitability headwinds for FY2026.
For a balanced, moderate-risk investor, EL looks more like a Hold than a clean Buy at current levels. The company has enough brand power, gross margin strength, and restructuring momentum to support recovery, but the stock already trades at 25.25x forward earnings despite a still-fragile earnings base and a consensus target of $94.91. That combination leaves room for upside if Beauty Reimagined keeps working, but not much room for operational slippage.
Estée Lauder(EL) is a global prestige beauty company headquartered in New York and founded in 1946. It operates across skin care, makeup, fragrance, and hair care, selling through department stores, duty-free retailers, specialty multi-brand retailers, pharmacies, salons, freestanding stores, brand websites, and third-party online platforms. The company employs 40,470 people and trades on the NYSE.
Its brand portfolio is unusually deep for a prestige beauty company. Core names include Estée Lauder, La Mer, Clinique, M·A·C, The Ordinary, Jo Malone London, TOM FORD, Le Labo, Aveda, Bobbi Brown, Too Faced, Bumble and bumble, Dr.Jart+, KILIAN PARIS, and several others. That breadth matters because it gives EL exposure to multiple price tiers, channels, and consumer occasions rather than relying on a single hero label.
Management is now framing the business around the Beauty Reimagined strategy and the Profit Recovery and Growth Plan, or PRGP. CEO Stéphane de La Faverie said on the fiscal Q2 2026 call, “We reported strong second quarter results, marked the one-year anniversary of Beauty Reimagine, and raised our fiscal 2026 outlook.”
That strategic reset is not cosmetic. It is aimed at shifting channel mix, speeding up innovation, lifting consumer-facing investment, and taking cost out of the system. In plain English, EL is trying to rebuild growth while fixing the machine underneath it. That is harder than launching another serum, but it is the right problem to solve.
EL reports product-category exposure that shows where the business still earns its prestige status and where it needs repair. In FY2025, skin care generated $6.962B, or 48.9% of total revenue. Makeup contributed $4.205B, or 29.6%. Fragrance added $2.491B, or 17.5%. Hair care remained small at $565M, or 4.0%.
Skin care remains the economic center of gravity, but it has been shrinking. Segment revenue fell from $8.202B in FY2023 to $7.908B in FY2024 and then to $6.962B in FY2025. That decline explains much of the company’s broader revenue pressure. The good news is that recent quarterly commentary points to stabilization, with Q2 FY2026 skin care organic sales up 6% and Q3 FY2026 skin care roughly flat, supported by La Mer and The Ordinary.
Makeup has also contracted, though less dramatically. Revenue moved from $4.516B in FY2023 to $4.470B in FY2024 and $4.205B in FY2025. In Q3 FY2026, makeup sales were virtually flat, driven by growth from Estée Lauder and offset by declines from Clinique and Too Faced. That is not a full recovery, but it is better than a category still sliding downhill.
Fragrance is the standout. Revenue held roughly steady over the last three fiscal years at $2.512B in FY2023, $2.487B in FY2024, and $2.491B in FY2025, but the recent trend is stronger than those annual numbers suggest. In Q3 FY2026, fragrance sales were up double digits, led by TOM FORD, Le Labo, Jo Malone London, and KILIAN PARIS. Management also called fragrance the best-performing category in the first half of FY2026, with 10% organic sales growth.
Hair care is small enough that it will not drive the whole equity story, but it can still help margin mix if it improves. Revenue declined from $653M in FY2023 to $629M in FY2024 and $565M in FY2025. Q3 FY2026 hair care sales were flat, with growth from The Ordinary offset by declines from Bumble and bumble and Le Labo. Small segment, mixed message.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
EL’s recovery depends less on abstract brand awareness and more on hero products that keep consumers in the franchise. The best current example is Double Wear. Management said Estée Lauder’s Double Wear Concealer was the top-ranked new product in U.S. prestige makeup by unit sales for calendar 2025. The company then followed that with the next-generation Double Wear Stay-in-Place Longwear Matte Foundation launch in February 2026, adding more shades, longer wear, and skincare benefits.
That matters because hero franchises do three jobs at once. They recruit new users, support repeat purchase, and create permission for adjacent launches. In beauty, one winning SKU often behaves like a lead singer dragging the rest of the band back on key.
In skin care, La Mer remains one of the company’s strongest premium engines. Q3 FY2026 skin care performance was supported by high single-digit growth at La Mer, and the brand extended its Night Collection with The NEW Rejuvenating Night Eye Cream in March 2026. Management also highlighted strong campaign performance around key shopping events, which contributed to La Mer being the best-performing brand in FY2026 by organic sales growth.
The Ordinary is another critical product platform, especially because it broadens EL’s reach beyond classic department-store prestige. Management said The Ordinary delivered strong double-digit retail sales growth in the first half of FY2026 and helped the company gain U.S. skincare value share. That is strategically important because it gives EL a science-led, value-conscious prestige brand at a time when consumers are becoming more selective.
In fragrance, TOM FORD, Le Labo, Jo Malone London, and KILIAN PARIS are doing the heavy lifting. Q3 FY2026 fragrance sales rose double digits, and management cited TOM FORD’s launches of Figue Érotique Eau de Parfum, Architecture Radiance Hydrating Foundation, and the relaunched Runway Eye Color Quad. Fragrance is where EL currently looks most in tune with the market rather than one step behind it.
EL’s moat starts with brand equity, but the more relevant question is whether that moat is still producing growth. Recent evidence says yes, though unevenly. Management said innovation is on track to represent at least 25% of FY2026 sales, and the share of innovation launched in less than a year is tracking to 19%, above the initial 16% expectation. Faster innovation cycles matter in beauty because trend windows have shortened and social commerce compresses the time between discovery and purchase.
The company is also trying to modernize how innovation reaches consumers. Management said EL now has 12 brands in Amazon Premium Beauty across 10 markets and has expanded onto TikTok Shop in the U.S. and Southeast Asia, while also launching in the U.K. and Germany. That channel expansion helped drive high single-digit online organic sales growth in the first half of FY2026.
There is also a structural advantage in portfolio breadth. Few prestige beauty players can cover ultra-luxury skin care, masstige-style science skin care, classic makeup, niche fragrance, and salon hair care under one roof. That gives EL more levers to rotate capital toward stronger categories. Right now, fragrance and select skin care brands are carrying more of the load while weaker areas are being repaired.
The risk is that a broad portfolio can become a museum if execution slows. EL seems aware of that. Management highlighted a simplified operating model called One ELC, plus partnerships with Accenture, Microsoft, Google, and Shopify to improve speed, data use, and shared services. Those moves do not guarantee success, but they do show the company is attacking the process problem, not just the marketing symptom.
The operational story is one of the strongest parts of the turnaround. In Q2 FY2026, gross margin expanded 40 bps to 76.5%, and in Q3 FY2026 gross margin expanded 140 bps to 76.4%. Management attributed the improvement to PRGP benefits, operational efficiencies, lower excess and obsolete inventory, and zero-waste initiatives.
Adjusted operating margin tells the cleaner story. It rose to 15.0% in Q3 FY2026 from 11.4% a year earlier, even as reported operating margin fell to 6.7% because of charges and other items. That split matters. The reported number shows the cost of restructuring. The adjusted number shows the earnings power management is trying to restore.
The company is also changing its service architecture. CFO Akhil Shrivastava said EL entered a strategic agreement for enterprise business services that consolidates providers, expands outsourced services, and standardizes end-to-end processes using advanced technology. Through December 31, cumulative restructuring charges tied to these efforts were $904M, primarily employee-related.
CapEx discipline is helping cash flow. For the first six months of FY2026, CapEx was $204M, down 25% from the prior year. For the first nine months, CapEx was $306M versus $395M a year earlier. EL is still funding consumer-facing investments, but it is trimming elsewhere. That is exactly what a sensible turnaround should do: spend where the customer notices, cut where the org chart notices.
Supply-chain risk has not disappeared. Management flagged tariff headwinds, travel retail disruption, and some near-term cost pressure as systems migrate. But the margin and cash-flow data show the company is getting more disciplined, not less.
EL operates in a large and still-growing beauty market. Grand View Research estimated the global beauty and personal care market at $557.24B in 2023 and projects it to reach $937.13B by 2030, a 7.7% CAGR. Mordor Intelligence estimated the personal care products market at $563.23B in 2026, rising to $726.9B by 2031 at a 5.24% CAGR. The exact number varies by definition, but the direction is clear: this is not a shrinking pond.
Within that market, prestige fragrance remains the hottest lane. Circana said U.S. prestige beauty sales grew 4% to $36B in 2025, with prestige fragrance up 5% after several years of outsized growth. That lines up neatly with EL’s own results, where fragrance was the best-performing category in the first half of FY2026 and rose double digits in Q3.
Skin care remains a large profit pool, but consumer behavior is shifting toward efficacy, science-backed claims, and value-conscious premium choices. That favors brands like The Ordinary and clinically positioned franchises, while making it harder for slower-moving prestige brands to coast on heritage alone.
Makeup is more mixed. Hybrid products that combine color and skincare benefits are gaining traction, and EL’s Double Wear refresh fits that trend. But makeup is also more trend-sensitive and more exposed to social-media velocity, which means execution has to stay sharp.
From a market-share standpoint, management said EL gained share in the U.S., China, Japan, and France across parts of calendar 2025, with strength led by brands such as La Mer, TOM FORD, The Ordinary, M·A·C, and Le Labo. Those are encouraging signs because share gains matter more than raw growth when a company is rebuilding from a weaker base.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
EL’s customer base spans multiple prestige beauty cohorts rather than one narrow demographic. At the high end, La Mer, TOM FORD, Le Labo, Jo Malone London, and KILIAN PARIS serve affluent consumers seeking luxury positioning, gifting appeal, and sensory differentiation. In the middle, Estée Lauder, Clinique, and M·A·C serve broad prestige consumers through department stores, specialty retail, and online. The Ordinary adds a more ingredient-focused, value-aware customer who still wants prestige credibility.
That mix is useful in the current environment. Gartner reported that 70% of U.S. consumers were making significant spending changes in 2025, including trading down and buying smaller sizes. EL cannot ignore that pressure, but The Ordinary gives it a bridge to consumers who want results without paying La Mer prices.
Younger consumers also matter more than they used to. McKinsey noted that Gen Z is over-indexing on appearance and self-care spending, while social commerce is compressing the funnel from discovery to purchase. EL’s expansion on Amazon Premium Beauty and TikTok Shop is therefore not just channel experimentation. It is a customer-acquisition move aimed at where beauty shopping behavior is already going.
Geographically, the customer profile remains global and uneven. Mainland China was a bright spot in Q3 FY2026, with net sales up 11% reported and 6% organically. The Americas were weaker, with Q3 net sales up just 1% reported and flat organically. That regional split shows EL still has a customer-relevance gap in some Western channels even as parts of Asia improve.
EL competes against global beauty heavyweights including L’Oréal, Coty, Shiseido, LVMH Beauty, and Puig. L’Oréal is the broadest and strongest scale player, with €44.05B of 2025 sales. Coty is a direct competitor in prestige fragrance and makeup. Shiseido matters in Asia and skin care. LVMH Beauty and Puig are especially relevant in luxury fragrance.
EL’s edge versus many peers is its concentration in prestige beauty and the depth of its brand portfolio. It is not trying to be everything to everyone. It is trying to own the premium shelf, the premium click, and the premium gifting moment. That focus can support better gross margins, and EL’s 74.3% gross margin on a trailing basis shows the model still has pricing power.
Its weakness versus the strongest peers is execution consistency. Annual operating margin fell from 17.9% in FY2022 to 6.7% in FY2025. Revenue has declined for three straight years through FY2025. That is the kind of slippage that stronger operators punish quickly. Prestige beauty is forgiving to great brands, but not indefinitely.
The current competitive picture therefore looks mixed but improving. EL is winning in fragrance, seeing encouraging traction in select skin care and makeup franchises, and rebuilding online reach. But it is still working through channel resets, travel retail disruption, and legacy share losses in the Americas. This is a fight, not a victory lap.
Macro matters more for EL than for a purely domestic staples company because its revenue base is global and its channel mix includes travel retail. Management repeatedly flagged macroeconomic, geopolitical, and retailer-specific uncertainty in FY2026 guidance. The biggest named issues are subdued Chinese consumer sentiment, travel retail disruption in Asia, and tariff-related cost pressure.
Tariffs are a direct profitability headwind. Management said FY2026 would face about $100M of tariff-related profitability pressure, mostly in the second half. In Q3 FY2026, the company also cited the estimated unfavorable impact of recently enacted U.S. tax legislation, which pushed the reported effective tax rate to 50.3% from 34.0% a year earlier.
Travel retail remains the messiest geopolitical-commercial intersection. Management described disruption tied to retailer changes in Beijing and Shanghai airports and the related online businesses. At the same time, Hainan has improved, with management saying January performance there was high double-digit and market share gains broadened across brands including Estée Lauder, La Mer, M·A·C, Jo Malone, and TOM FORD.
The Americas are also feeling macro strain. Management said Latin America slowed as tariffs started to hurt consumer confidence. That matters because a turnaround needs several regions pulling together, not one region bailing out another.
The bottom line is straightforward: EL is not a defensive utility wrapped in lipstick. It sits in consumer staples classification, but its earnings path is still sensitive to global travel, China demand, trade policy, and premium consumer confidence.
Debt stood at $7.72B versus $2.92B of cash at June 30, 2025, and annual debt-to-equity reached 2.00, leaving the balance sheet workable but not especially flexible.
Unlock the full analysis
Subscribers get the complete breakdown — grades, rationale, and specific targets.
Get Full AccessFY2025 revenue fell to $14.29B and net income swung to a $1.13B loss, even as Q3 FY2026 adjusted EPS rebounded 40% to $0.91 and margins expanded.
Unlock the full analysis
Subscribers get the complete breakdown — grades, rationale, and specific targets.
Get Full AccessManagement raised FY2026 guidance to high-end 1%-3% organic sales growth and 10.7%-11.0% adjusted operating margin, signaling improving execution.
Unlock the full analysis
Subscribers get the complete breakdown — grades, rationale, and specific targets.
Get Full AccessAt 25.25x forward earnings, EL trades above a still-fragile earnings base and leaves less room for disappointment than the recovery story suggests.
Unlock the full analysis
Subscribers get the complete breakdown — grades, rationale, and specific targets.
Get Full AccessWith a consensus target of $94.91 and a fair value of $95, the stock appears close to fully valued despite improving operating momentum.
Unlock the full analysis
Subscribers get the complete breakdown — grades, rationale, and specific targets.
Get Full AccessEstée Lauder(EL) is not broken in the way weak brands break. Its gross margins remain elite, its fragrance portfolio is firing, hero products like Double Wear are working, The Ordinary is broadening reach, and management is finally producing visible operating leverage. Those are serious positives.
But the company is also not fully healed. Revenue is still below prior peaks, FY2025 ended with a net loss, leverage is elevated versus history, and several external variables still matter too much. That keeps the stock in the middle lane rather than the fast lane.
For investors with moderate risk tolerance, EL looks worth owning only at the right price. The fair value estimate remains $95, and the current setup supports patience over aggression. The business is improving. The stock, however, already knows that.
EL is a Hold right now, not a Buy. The business is improving with stronger sales, margin expansion, and better cash generation, but the stock already trades near fair value and still faces tariff, travel retail, and leverage risks.
Estée Lauder's fair value is $95. That lines up closely with the $94.91 consensus target and reflects a mix of improving FY2026 guidance, a 25.25x forward earnings multiple, and the fact that recovery is real but not yet fully de-risked.
Estée Lauder is only a Hold because the turnaround is promising but not complete. Revenue has fallen from $17.74B in FY2022 to $14.29B in FY2025, FY2025 was a $1.13B loss, and the company still faces about $100M of tariff-related headwinds in FY2026.
The recovery is being driven by Beauty Reimagined, stronger fragrance momentum, and improving skin care performance. Q3 FY2026 organic sales rose 2%, adjusted operating margin expanded 360 bps to 15.0%, and brands like La Mer, The Ordinary, TOM FORD, and Le Labo are helping lead the rebound.
The biggest risks are execution, leverage, and channel disruption. Debt was $7.72B versus $2.92B of cash at June 30, 2025, travel retail in Asia remains pressured, and the company still needs to prove the recovery can hold across skin care and makeup.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access
The Estée Lauder Companies Inc. (EL) posted a solid earnings beat, and the stock gained as investors looked past the headline to the deeper turnaround story. Stronger margins, raised guidance, and fragrance-led momentum added credibility to the recovery, while management’s outlook suggested more room for gains ahead.

The Estée Lauder Companies Inc. (EL) rises 6.5% after posting earnings beats, lifting shares as investors react to stronger-than-expected quarterly results.

The Estée Lauder Companies Inc. (EL) climbs after fiscal Q3 results topped revenue expectations and management raised full-year guidance. Investors are reacting to improving demand in China and Europe, double-digit fragrance growth, and a turnaround plan that appears to be gaining traction.